Roche's Star MS Drug Snags EU Approval By Sam | January 11, 2018 The EU approval is based on data from three pivotal Phase III studies from the ORCHESTRA trial programme of 2,388 patients who met primary and nearly all key secondary endpoints. Source: BioSpace Posted in BioPharma